期刊文献+

整合医学理念对肝癌临床诊治的启示 被引量:7

原文传递
导出
摘要 整合医学是哲学概念向诊断治疗学演变的结果,是将医学各领域最先进理论、临床各专科最有效的实践经验分别加以有机整合,并根据社会、环境、心理的现实进行修整、调整,使之成为更加符合、适合人体健康和疾病治疗的医学新体系。
作者 陆伟
出处 《中华消化杂志》 CAS CSCD 北大核心 2013年第10期658-660,共3页 Chinese Journal of Digestion
  • 相关文献

参考文献10

  • 1Villa E, Moles A, Ferretti I, et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology, 2000, 32 : 233 238.
  • 2Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology, 2011,53:1020-1022.
  • 3Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int, 2010,4:439-474.
  • 4原发性肝癌规范化诊治的专家共识[J].中华肝脏病杂志,2009,17(6):403-410. 被引量:104
  • 5Caldwell S, Park SH. The epidemiology of hepatocellular cancer= from the perspectives of public health problem to tumor biology. J Gastroenterol, 2009,44 Suppl 19:S96 -101.
  • 6Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma an updated analysis of randomized controlled trials. Aliment Pharmacol Ther, 2006, 23 : 1535-1547.
  • 7Hilgard P, Muller S, Gerken G, et al. Radio embolization with yttrium-90 microspheres for hepatocellular carcinoma methods and results. Eur Gastroenterol Hepatol Rev, 2010, 6: 82-89.
  • 8陆伟.局部消融治疗超适应证范围肝癌的现状[J].中华肝脏病杂志,2012,20(4):253-255. 被引量:2
  • 9Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology, 2004,40 : 1352-1360.
  • 10Bouchard MJ, Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett, 2011,305:123-143.

二级参考文献6

共引文献104

同被引文献60

  • 1章毅.原发性肝癌TACE术相关并发症与处理[J].中国医药指南,2008,6(21):87-88. 被引量:4
  • 2曹霖,汪晓东,李立.多学科协作诊治模式的会诊流程探讨(一)[J].中国普外基础与临床杂志,2007,14(3):343-345. 被引量:51
  • 3叶建伟,张勇,徐苓,朱大海.医学发展的未来:从基因组学到整合医学[J].中华医学杂志,2007,87(27):1873-1875. 被引量:10
  • 4hoh S,Ikeda Y,Kawanaka H,et al. Efficacy of surgical mi- crowave therapy in patients with unresectable hepatocellular carcinoma. Ann Surg Oncol, 2011,18( 13 ):3650-3656.
  • 5Bmix J,Sherman M. American Association for the Study of Liver Disease. Management of hepatocellular carcinoma:an update. Hepatology, 2011,53(3 ) : 1020-1022.
  • 6Yin XY,Xie XY,Lu MD,et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma:long-term out- and prognostic factors. Cancer,2009,115 (9):1914- 1923.
  • 7Ryosuke I,Toshihito S,Kozo I,et al. Percutaneous microwave coagulation therapy for hepatocellular carcinoma: Increased coagulation diameter using a new electrode and microwave generator. Oncol Reports, 2010,24(3 ):621-627.
  • 8Nakazawa T,Kokubu S,Shibuya A,et al.Radiofrequency ab- lation of hepatocellular carcinoma:correlation between local tumor progression after ablation and ablative margin.A JR, 2007,188(2) :480-488.
  • 9Seki T,Tamai T,Nakagawa T,et al. Combination therapy with transcatheter arterial ehemoembolization and percuta- neous microwave coagulation therapy for hepatoeellular carcinoma. Cancer, 2000,89(6):1245-1251.
  • 10Ng KK,Poon RT,Lo CM,et al. Analysis of recurrence pat- tern and its influence on survival outcome after radiofre- quency ablation of hepatoeellular careinoma.Gastrointest Surg, 2008,12( 1 ):183-191.

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部